𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term follow-up of the first in man experience with everolimus-eluting stents

✍ Scribed by Carey Kimmelstiel

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
37 KB
Volume
75
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug eluting stents for below the knee l
Drug eluting stents for below the knee lesions in patients with critical limb ischemia : Long-term follow-up
✍ Oscar R. Rosales; Shiny Mathewkutty; Charlie Gnaim 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 1 views

## Abstract Objectives: The purpose of this study was to assess the long‐term limb preservation and/or healing of ulcers in patients with critical limb ischemia (CLI) and severe infrapopliteal atherosclerotic disease treated with drug eluting stents (DES). Background: Percutaneous revascularization

Five-year clinical follow-up after impla
Five-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, first-in-human study
✍ Ian T. Meredith; John Ormiston; Robert Whitbourn; I. Patrick Kay; David Muller; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

## Abstract Objective: To evaluate the 5‐year clinical outcomes of patients treated with the Endeavor zotarolimus‐eluting stent (ZES) in the ENDEAVOR I first‐in‐human study. Background: ENDEAVOR I was a prospective, nonrandomized, multicenter study of the Endeavor ZES in 100 consecutive patients wi

Chronic total occlusion treatment in pos
Chronic total occlusion treatment in post-CABG patients: Saphenous vein graft versus native vessel recanalization—Long-term follow-up in the drug-eluting stent era
✍ Emanuele Meliga; Héctor M. García-García; Neville Kukreja; Joost Daemen; Shuzou 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

## Abstract ## Objective: To compare the postprocedural and long‐term clinical outcomes of two groups of patients, all presenting with chronic saphenous vein graft (SVG) occlusion, who underwent either SVG or native vessel reopening. ## Background: Chronic total occlusions (CTO) treatment in pat

Four-year clinical follow-up of the XIEN
Four-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT II trial
✍ Scot Garg; Patrick W. Serruys; Karine Miquel-Hebert; on behalf of the SPIRIT II 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 2 views

## Abstract This report describes the 4‐year clinical outcomes of the SPIRIT II study, which randomized 300 patients to treatment with the XIENCE V everolimus‐eluting stent (EES), or the TAXUS paclitaxel‐eluting stent. At 4‐year clinical follow‐up, which was available in 256 (85.3%) patients, treat